Invention Grant
- Patent Title: Oral soft gel capsule containing psychedelic compound
-
Application No.: US16947003Application Date: 2020-07-14
-
Publication No.: US11766445B2Publication Date: 2023-09-26
- Inventor: Tony LaRosa , Robert Davidson , David Reid
- Applicant: Concept Matrix Solutions
- Applicant Address: US CA Newbury Park
- Assignee: Concept Matrix Solutions
- Current Assignee: Concept Matrix Solutions
- Current Assignee Address: US CA Newbury Park
- Agency: Carlson, Caspers, Vandenburgh & Lindquist, P.A.
- Main IPC: A61K31/675
- IPC: A61K31/675 ; A61K9/48 ; A61K31/4045

Abstract:
Provided is an oral soft gel capsule that includes a psychedelic compound. Also provided is a method of treating in a subject a disease or disorder ameliorated by a psychedelic compound, that includes orally administering to a subject an oral soft gel capsule that includes a therapeutically effective amount of the psychedelic compound. Also provided is a method of orally administering to a subject an oral soft gel capsule that includes a therapeutically effective amount of the psychedelic compound. Also provided is a method of orally administering to a subject an oral soft gel capsule that includes a low dose (e.g., microdose or sub-therapeutic dose) of the psychedelic compound.
Public/Granted literature
- US20210015833A1 ORAL SOFT GEL CAPSULE CONTAINING PSYCHEDELIC COMPOUND Public/Granted day:2021-01-21
Information query